Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Gene therapy

XyloCor Therapeutics
Regional

XyloCor Doses First Patient in Pivotal Gene Therapy Trial for Refractory Angina

July 15, 2025July 14, 2025 - by Timothy Alexander

KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients …

XyloCor Doses First Patient in Pivotal Gene Therapy Trial for Refractory Angina Read More

AscellaHealth
Business

AscellaHealth’s Latest Digest Tracks Surge in Specialty and Rare Disease Drug Approvals

July 11, 2025July 10, 2025 - by Timothy Alexander

BERWYN, PA — AscellaHealth has released its Q2 2025 Specialty & Rare Pipeline Digest™, offering stakeholders a detailed look at the rapidly evolving landscape of specialty and rare disease therapies. The …

AscellaHealth’s Latest Digest Tracks Surge in Specialty and Rare Disease Drug Approvals Read More
Passage Bio
Regional

Passage Bio Reports Progress in Gene Therapy for Frontotemporal Dementia

June 24, 2025June 23, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) has announced encouraging updates from the ongoing Phase 1/2 upliFT-D clinical trial for PBFT02, a one-time gene therapy for frontotemporal dementia (FTD) …

Passage Bio Reports Progress in Gene Therapy for Frontotemporal Dementia Read More

Latus Bio
Regional

Latus Bio Unveils Breakthrough in Gene Therapy for Neurodegenerative Diseases

May 27, 2025May 26, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio, Inc. has announced a significant advancement in the field of gene therapy with the publication of its latest research in Nature Communications. The study, led …

Latus Bio Unveils Breakthrough in Gene Therapy for Neurodegenerative Diseases Read More
Person looking through the microscope
Regional

VintaBio Showcases Breakthrough Gene Therapy Manufacturing Platform

May 21, 2025May 20, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Last week, VintaBio presented promising new data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, spotlighting its proprietary VintaProcess™. This innovative platform …

VintaBio Showcases Breakthrough Gene Therapy Manufacturing Platform Read More

Latus Bio
Regional

Latus Bio Announces Breakthrough in Gene Therapy with AAV-Ep+ Capsid

May 21, 2025May 20, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio, Inc. has unveiled groundbreaking research on a novel adeno-associated virus (AAV) capsid variant, AAV-Ep+, which shows significant promise for advancing gene therapy applications. Published in …

Latus Bio Announces Breakthrough in Gene Therapy with AAV-Ep+ Capsid Read More
Latus Bio
Regional

Latus Bio to Spotlight Advances in Gene Therapy at ASGCT Annual Meeting

May 7, 2025May 6, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Latus Bio Inc. (Latus) will showcase its groundbreaking progress in AAV capsid variants—AAV-DB-3 and AAV-Ep+—at the 2025 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting …

Latus Bio to Spotlight Advances in Gene Therapy at ASGCT Annual Meeting Read More

Posts pagination

Previous 1 … 3 4

Trending News

  • Man Accused of Stealing Packages, Entering Garage in Lancaster

  • Lancaster Man Convicted of Strangling Woman Three Times

  • Pottstown Foundation Offers $3,000 in Student Loan Relief

  • Police Seek Suspect in $200 PlayStation Controller Theft

  • Cecil College Earns Spot on TIME’s Top 250 Community Colleges

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Victor Jose Rivera-Rodriguez

Man Accused of Stealing Packages, Entering Garage in Lancaster

November 21, 2026November 20, 2026

Court News

Lancaster Man Convicted of Strangling Woman Three Times

November 21, 2026November 20, 2026

suspect

Police Seek Suspect in $200 PlayStation Controller Theft

November 21, 2026November 20, 2026

Copyright © 2026 MyChesCo.